NobleOak Life Limited Price Chart
NobleOak Life Limited NOL.XA Financial and Trading Overview
| NobleOak Life Limited stock price | 1.36 AUD |
| Previous Close | 1.73 AUD |
| Open | 1.73 AUD |
| Bid | 1.66 AUD x N/A |
| Ask | 1.78 AUD x N/A |
| Day's Range | 1.73 - 1.73 AUD |
| 52 Week Range | 1.57 - 2.19 AUD |
| Volume | 152 AUD |
| Avg. Volume | 1.04K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NOL.XA Valuation Measures
| Enterprise Value | 61.68M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2776958 |
| Enterprise Value/Revenue | 0.67 |
| Enterprise Value/EBITDA | 8.034 |
Trading Information
NobleOak Life Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -4.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.19 AUD |
| 52 Week Low | 1.57 AUD |
| 50-Day Moving Average | 1.75 AUD |
| 200-Day Moving Average | 1.8 AUD |
NOL.XA Share Statistics
| Avg. Volume (3 month) | 1.04K AUD |
| Avg. Daily Volume (10-Days) | 619 AUD |
| Shares Outstanding | N/A |
| Float | 53.87M |
| Short Ratio | N/A |
| % Held by Insiders | 31.14% |
| % Held by Institutions | 58.22% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 4.67% |
| Operating Margin (ttm) | 7.74% |
| Gross Margin | 33.83% |
| EBITDA Margin | 8.34% |
Management Effectiveness
| Return on Assets (ttm) | 2.85% |
| Return on Equity (ttm) | 3.76% |
Income Statement
| Revenue (ttm) | 92.01M AUD |
| Revenue Per Share (ttm) | 1.03 AUD |
| Quarterly Revenue Growth (yoy) | 21.39% |
| Gross Profit (ttm) | 27.43M AUD |
| EBITDA | 7.68M AUD |
| Net Income Avi to Common (ttm) | 4.3M AUD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 132.29% |
Balance Sheet
| Total Cash (mrq) | 93.13M AUD |
| Total Cash Per Share (mrq) | 1.08 AUD |
| Total Debt (mrq) | 6.09M AUD |
| Total Debt/Equity (mrq) | 5.24 AUD |
| Current Ratio (mrq) | 0.967 |
| Book Value Per Share (mrq) | 1.354 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 50.9M AUD |
| Levered Free Cash Flow (ttm) | 11.85M AUD |
Profile of NobleOak Life Limited
| Country | Australia |
| State | NSW |
| City | Sydney |
| Address | 66 Clarence Street |
| ZIP | 2000 |
| Phone | 61 2 8123 2622 |
| Website | https://www.nobleoak.com.au |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
NobleOak Life Limited manufactures and distributes life insurance products in Australia. The company offers term death, total and permanent disability, trauma, and income protection and business expenses insurance products. It sells its products through direct-to-market and alliance partners, as well as strategic partner channels. The company was founded in 1861 and is headquartered in Sydney, Australia.
Q&A For NobleOak Life Limited Stock
What is a current NOL.XA stock price?
NobleOak Life Limited NOL.XA stock price today per share is 1.36 AUD.
How to purchase NobleOak Life Limited stock?
You can buy NOL.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NobleOak Life Limited?
The stock symbol or ticker of NobleOak Life Limited is NOL.XA.
How many shares does NobleOak Life Limited have in circulation?
The max supply of NobleOak Life Limited shares is 0.
What is NobleOak Life Limited Price to Earnings Ratio (PE Ratio)?
NobleOak Life Limited PE Ratio is now.
What was NobleOak Life Limited earnings per share over the trailing 12 months (TTM)?
NobleOak Life Limited EPS is 0 AUD over the trailing 12 months.